Post-Marketing Safety Surveillance of Vaccines in Japan for Older Adults: A Feasibility Assessment of Real-World Data Capabilities

被引：0
|
作者：
Zhou, Cindy Ke [1 ]
Yasui, Daisaku [1 ]
Yoshinaga, Eiko [1 ]
Pearce, Kristina [1 ]
Martin, David [1 ]
Esposito, Daina B. [1 ]
Kubo, Tadamichi [1 ]
机构：
[1] Moderna Inc, Cambridge, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
649
引用
收藏
页码：274 / 275
页数：2
相关论文
共 50 条
  • [31] Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan
    Inoue, Yoshikazu
    Ogura, Takashi
    Azuma, Arata
    Kondoh, Yasuhiro
    Homma, Sakae
    Muraishi, Kenya
    Ikeda, Rie
    Ochiai, Kaori
    Sugiyama, Yukihiko
    Nukiwa, Toshihiro
    ADVANCES IN THERAPY, 2025, 42 (02) : 1075 - 1093
  • [32] Real-world experience with eculizumab in Japanese patients with myasthenia gravis: Post-marketing surveillance data
    Takahashi, M.
    Masuda, M.
    Watanabe, M.
    Fukamizu, Y.
    Osawa, T.
    Kikui, H.
    Murai, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 574 - 574
  • [33] Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data
    Shao, Qi-hui
    Yin, Xue-dong
    Liu, Hong-xia
    Zhao, Bin
    Huang, Jian-quan
    Li, Zhi-ling
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [34] Real-world safety of the novel, free radical scavenger edaravone for amyotrophic lateral sclerosis patients: Data from the post-marketing surveillance SUNRISE Japan
    Ishizaki, Kaoru
    Yoshimura, Kenta
    Yoshida, Kengo
    Matsuda, Masao
    Kawaguchi, Yutaka
    Yuki, Satoshi
    Sobue, Gen
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2021, 9 (03): : 223 - 229
  • [35] Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan
    Ohno-Matsui, Kyoko
    Suzaki, Makoto
    Teshima, Rie
    Okami, Nina
    EYE, 2018, 32 (12) : 1871 - 1878
  • [36] Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan
    Kyoko Ohno-Matsui
    Makoto Suzaki
    Rie Teshima
    Nina Okami
    Eye, 2018, 32 : 1871 - 1878
  • [37] Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan
    Hayashi, Nobukazu
    Hayama, Koremasa
    Takahashi, Kenzo
    Kurokawa, Ichiro
    Okazaki, Masateru
    Kashiwagi, Tomoko
    Iwashita, Eri
    Terui, Tadashi
    JOURNAL OF DERMATOLOGY, 2022, 49 (04): : 411 - 421
  • [38] A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data
    Du, Yikuan
    Zhang, Mengting
    Wang, Zhenjie
    Hu, Mianda
    Xie, Dongxia
    Wang, Xiuzhu
    Guo, Zhuoming
    Zhu, Jinfeng
    Zhang, Weichui
    Luo, Ziyi
    Yang, Chun
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (10) : 1422 - 1433
  • [39] A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
    Zhang, Qilin
    Ding, Yiling
    Shu, Yamin
    Chen, Jing
    BMC CANCER, 2023, 23 (01)
  • [40] A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
    Qilin Zhang
    Yiling Ding
    Yamin Shu
    Jing Chen
    BMC Cancer, 23
12345